Last reviewed · How we verify
NCT06363682: EndoscopX
Interventional Reference Levels (IRL) in Digestive Endoscopy
trial testing ERCP in Each Endoscopic Intervention Using X-rays in 1,000 participants. Status unknown.
11 June 2024
Quick facts
| Lead sponsor | Central Hospital, Nancy, France |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 1 April 2024 |
| Primary completion | 11 June 2024 |
| Estimated completion | 11 June 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- ERCP
- endoscopic ultrasound
- gastroscopy
- Colonoscopy
- placement of a nasojejunal tube
Conditions studied
- Each Endoscopic Intervention Using X-rays — all drugs for Each Endoscopic Intervention Using X-rays →
Sponsor
Central Hospital, Nancy, France
Who can join
18 and older, any sex, with Each Endoscopic Intervention Using X-rays. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Scopy uses X-rays and is not without risk (deterministic and stochastic effects) for the patient and the nursing staff present in the room at the time of an endoscopic procedure requiring its use: its use must be reasoned with a benefit/risk balance in favour of carrying out the interventional procedure. In France, there is currently no multicentre study exploring the radiation doses used for each type of endoscopic procedure. Main objective: To define IRL (interventional reference levels) adapted to each type of endoscopic procedure. Secondary objective(s) : * Application of regulatory texts * Assessment of patient radiation protection * Radiation protection assessment for workers
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06363682
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ERCP
Trials testing the same drug.
- NCT07455227 — ERCP Management in Mild Gallstone-Induced Pancreatitis Patients Declining Subsequent Cholecystectomy : a Randomized Cont · NA · not yet recruiting
- NCT06900790 — Management of Pediatric Pancreatic Calculi At a Single Center: a Retrospective Cohort Study · not yet recruiting
- NCT06456476 — Patients With Obstructive Jaundice In Sohag University Hospital · recruiting
- NCT06197984 — Antimicrobial Resistance in Acute Cholangitis · recruiting
- NCT05920954 — Urgent (<24 Hours) Versus Early (24 to 48 Hours) ERCP for Patients With Mild and Moderate Acute Cholangitis · NA · completed
Other Central Hospital, Nancy, France trials
Trials by the same sponsor.
- NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
- NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
- NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
- NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
- NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06363682 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
- Last refreshed: 12 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06363682.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing